Skip to main content

Advertisement

Log in

Detection ofClostridium difficile toxin by enzyme immunoassay, tissue culture test and culture

Nachweis von Clostridium difficile Toxin mittels ELISA, Zellkulturtest und Kultur

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

Clostridium difficile toxin is frequently encountered in patients with antibiotic-associated diarrhea. A commercially available enzyme immunoassay (EIA) detecting toxins A and B was evaluated, screening 148 stool specimens specifically submitted for the detection ofC. difficile. A sensitivity of 100% and a specificity of 97.5% were found compared to a tissue culture assay. The overall prevalence ofC. difficile toxin was 22.1%. Cephalosporins had been administered significantly more often to toxin-positive patients. The EIA proved to be a suitable test for the detection ofC. difficile toxin, revealing high prevalences in specifically submitted clinical specimens.

Zusammenfassung

Clostridium difficile stellt eine der häufigsten Ursachen von antibiotika-assoziierten Diarrhöen dar. Wir untersuchten einen kommerziellen ELISA zum Nachweis der Toxine A und B anhand von 148 zum Nachweis vonC. difficile eingesandten Stuhlproben. Die Sensitivität des ELISA betrug, verglichen mit einem Zellkulturtest, 100%, die Spezifität lag bei 97,5%. Die Prävalenz vonC. difficile-Toxin wurde mit 22,1% bestimmt. Bei toxin-positiven Patienten war signifikant häufiger eine Therapie mit Cephalosporinen durchgeführt worden. Der Toxin A- und B-ELISA eignete sich gut zum Nachweis vonC. difficile-Toxin und erbrachte hohe Prävalenzen in zum Nachweis vonC. difficile eingesandten Proben.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lyerly, D. M., Krivan, H. C., Wilkins, T. D. Clostridium difficile: its disease and toxins. Clin. Microbiol. Rev. 1 (1988) 1–18.

    PubMed  Google Scholar 

  2. Fekety, R. Antibiotic-associated colitis. In:Mandell, G. L., Douglas, J. E., Bennett, J. E. (eds): Principles and Practice of Infectious Diseases. Churchill Livingstone, New York 1985, pp. 863–869.

    Google Scholar 

  3. Aronsson, B., Möllby, R., Nord, C. E. Antimicrobial agents andClostridium difficile in acute enteric disease: epidemiological data from Sweden. J. Infect. Dis. 151 (1985) 476–481.

    PubMed  Google Scholar 

  4. Hughes, J. M., Jarvis, W. R. Nosocomial gastrointestinal infections. In:Wenzel, R. P. (ed): Prevention and control of nosocomial infections. Williams and Wilkins, Baltimore 1987, pp. 405–439.

    Google Scholar 

  5. Liesenfeld, O., Weinke, T., Hahn, H. Three-year prevalence of enteropathogenic bacteria in an urban patient population in Germany. Infection 21 (1993) 101–105.

    PubMed  Google Scholar 

  6. Bender, B. S., Bennett, R., Laughon, B. E. IsClostridium difficile endemic in chronic-care facilities? Lancet ii (1986) 11–13.

    Google Scholar 

  7. McFarland, L. V., Mulligan, M. E., Kwok, R. Y., Stamm, W. E. Nosocomial acquisition ofClostridium difficile infection. N. Engl. J. Med. 320 (1989) 204–210.

    PubMed  Google Scholar 

  8. Bartlett, J. G. Clostridium difficile: Clinical considerations. Rev. Infect. Dis. 12 Suppl. 2 (1990) S243-S251.

    PubMed  Google Scholar 

  9. Lyerly, D. M., Phelps, C. J., Toth, J., Wilkins, T. D. Characterisation of toxins A and B ofClostridium difficile with monoclonal antibodies. Infect. Immun. 54 (1986) 70–76.

    PubMed  Google Scholar 

  10. Lima, A., Lyerly, D. M., Wilkins, T. D., Innes, D. J., Guerrant, R. L. Effects ofClostridium difficile toxins A and B in rabbit small and large intestinein vivo and on cultured cells. Infect. Immun. 56 (1988) 582–588.

    PubMed  Google Scholar 

  11. Lyerly, D. M., Saum, K. E., McDonald, D. K., Wilkins, T. D. Effects ofClostridium difficile toxins given intragastrically to animals. Infect. Immun. 47 (1985) 349–352.

    PubMed  Google Scholar 

  12. Chang, T. W., Lauermann, M., Bartlett, J. G. Cytotoxicity assay in antibiotic-associated colitis. J. Infect. Dis. 140 (1980) 765–770.

    Google Scholar 

  13. Kelly, M. T., Champagne, S. G., Sherlock, C. H., Noble, M. A., Freemann, H. J., Smith, J. A. Commercial latex agglutination test for the detection ofClostridium difficile associated diarrhea. J. Clin. Microbiol. 25 (1987) 1244–1247.

    PubMed  Google Scholar 

  14. Peterson, L. R., Olson, M. M., Shanholtzer, C. J., Gerding, D. N. Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing and culturette brand (CDT) latex testing in the diagnosis ofClostridium difficile associated disease. Diagn. Microbiol. Infect. Dis. 10 (1988) 85–91.

    PubMed  Google Scholar 

  15. Dipersio, J. R., Varga, F. J., Conwell, D. L., Kraft, J. A., Kozak, K. J., Willis, D. H. Development of a rapid enzyme immunoassay forClostridium difficile toxin A and its use in the diagnosis ofC. difficile-associated disease. J. Clin. Microbiol. 29 (1991) 2724–2730.

    PubMed  Google Scholar 

  16. DeGirolami, P. C., Hanff, P. A., Eichelberger, K., Longhi, L., Teresa, H., Pratt, J., Cheng, A., Letourneau, J. M., Thorne, G. M. Multicenter evaluation of a new enzyme immunoassay for detection ofClostridium difficile enterotoxin A. J. Clin. Microbiol. 30 (1992) 1085–1088.

    PubMed  Google Scholar 

  17. Barbut, F., Kajzer, C. H., Planas, N., Petit, J. C. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis ofClostridium difficile-associated diarrhea. J. Clin. Microbiol. 31 (1993) 963–967.

    PubMed  Google Scholar 

  18. Hutchinson, J., Shaw, H., Gordon, R., Laurie, W., Sharabadi, M. S., Church, D., Anand, C. M.: Detection ofClostridium difficile toxin by enzyme immuno assay tests. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA., 11–14. October 1992, Abstract Nr. 1255.

  19. Knapp, C. C., Webb, B., Ludwig, M., Beavis, K., Forstall, G., Rutherford, I., Hall, G. S.: Comparison of cytotoxin, three enzyme immunoassays and latex agglutination for diagnosis ofClostridium difficile-associated diarrhea. 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, CA., 11–14 October 1992, Abstract Nr. 1256.

  20. Coughlin, R. T., Fong, C., Brecher, S., Marciani, D., Pickett, M.: Comparison ofClostridium difficile cytotoxin titers with titers of toxin A and toxin B by enzymeimmunoassay (EIA). ASM National Meeting Poster 1991.

  21. DeLalla, F., Privitera, G., Ortisi, G., Rizzardini, G., Santoro, D., Pagano, A., Rinaldi, E., Scarpellini, P. Third generation cephalosporins as a risk factor forClostridium difficile-associated disease: a four-year survey in a general hospital. J. Antimicrob. Chemother. 23 (1989) 623–631.

    PubMed  Google Scholar 

  22. Siegel, D. L., Edelstein, P. H., Nachamkin, I. Inappropriate testing for diarrheal diseases in the hospital. JAMA 263 (1990) 979–982.

    PubMed  Google Scholar 

  23. Fan, K., Morris, A. J., Reller, L. B. Application of rejection criteria for stool cultures for bacterial enteric pathogens. J. Clin. Microbiol. 31 (1993) 2233–2235.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liesenfeld, O., Saeger, F. & Hahn, H. Detection ofClostridium difficile toxin by enzyme immunoassay, tissue culture test and culture. Infection 22, 29–32 (1994). https://doi.org/10.1007/BF01780761

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01780761

Keywords

Navigation